Freenome vs Tempus
Comprehensive comparison of two leading AI companies. Compare capabilities, pricing, security, and more to make an informed decision.
Freenome develops blood-based tests for early cancer detection using its multiomics platform that combines computational biology, machine learning, and advanced genomics. The company has raised $1.35B in total funding including …
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The company has built the world's largest library of clinical and molecular data …
Comparison Verdict
Both Freenome and Tempus are strong contenders - evaluate based on your specific requirements
Capabilities & Services
Freenome Only
No unique capabilities
Both Companies
No overlapping capabilities
Tempus Only
No unique capabilities
AI Modalities
Freenome Only
No unique modalities
Both Companies
No overlapping modalities
Tempus Only
No unique modalities
Pricing & Commercial
Freenome
Tempus
Operations & Scale
Freenome
Tempus
Similar Companies to Consider
Abridge
Abridge uses generative AI to automatically capture and summarize doctor-patient conversations into structured clinical notes. …
201-500Aidoc
Aidoc specializes in AI-powered solutions for radiology and medical imaging analysis, helping detect brain bleeds …
201-500PathAI
PathAI develops AI-powered technology that assists pathologists in making accurate diagnoses for cancer and other …
201-500Athelas
Athelas provides an AI-powered healthcare platform offering Revenue Cycle Management, Ambient AI for automated medical …
201-500Paige AI
Paige develops AI-native digital pathology products for cancer diagnosis and treatment. The company has built …
51-200Explore More Comparisons
Need More Information?
Explore detailed profiles of Freenome and Tempus to learn more about their services, case studies, and customer reviews.